Kallikrein 5 induces atopic dermatitis–like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Netherton syndrome (NS) is a severe genetic skin disease with constant atopic manifestations that is caused by mutations in the serine protease inhibitor Kazal-type 5 (SPINK5) gene, which encodes the protease inhibitor lymphoepithelial Kazal-type–related inhibitor (LEKTI). Lack of LEKTI causes stratum corneum detachment secondary to epidermal proteases hyperactivity. This skin barrier defect favors allergen absorption and is generally regarded as the underlying cause for atopy in NS. We show for the first time that the pro-Th2 cytokine thymic stromal lymphopoietin (TSLP), the thymus and activation-regulated chemokine, and the macrophage-derived chemokine are overexpressed in LEKTI-deficient epidermis. This is part of an original biological cascade in which unregulated kallikrein (KLK) 5 directly activates proteinase-activated receptor 2 and induces nuclear factor κB–mediated overexpression of TSLP, intercellular adhesion molecule 1, tumor necrosis factor α, and IL8. This proinflammatory and proallergic pathway is independent of the primary epithelial failure and is activated under basal conditions in NS keratinocytes. This cell-autonomous process is already established in the epidermis of Spink5−/− embryos, and the resulting proinflammatory microenvironment leads to eosinophilic and mast cell infiltration in a skin graft model in nude mice. Collectively, these data establish that uncontrolled KLK5 activity in NS epidermis can trigger atopic dermatitis (AD)–like lesions, independently of the environment and the adaptive immune system. They illustrate the crucial role of protease signaling in skin inflammation and point to new therapeutic targets for NS as well as candidate genes for AD and atopy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mutations or variants of genes such as SPINK5 favour the generation of allergen-independent, nonspecific inflammation, providing a pro-T helper 2 (TH2) micromilieu by virtue of keratinocyte-derived alarmins such as thymic stromal lymphopoietin (TSLP), IL-33 and IL-25 (refs52,64).”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [52]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The role of the innate immune system in the early phase of AD was demonstrated using animal models52–54 and is likely of clinical relevance in infancy55.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,599
Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
Soumelis, V., Reche, P. A., Kanzler, H., Yuan, W., Edward, G., Homey, B., Gilliet, M., Ho, S., Antonenko, S., Lauerma, A., et al. (2002) · Nature Immunology · doi:10.1038/ni805 · Cited by 2,183
The cornified envelope: a model of cell death in the skin
Candi, E., Schmidt, R., & Melino, G. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1619 · Cited by 1,776
Atopic dermatitis and the atopic march
Spergel, J. M., & Paller, A. S. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.09.033 · Cited by 1,229
Leung, D. Y., & Bieber, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12193-9 · Cited by 1,147
Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes
Rheinwald, J. G., & Green, H. (1977) · Nature · doi:10.1038/265421a0 · Cited by 1,066
Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris
Smith, F. J. D., Irvine, A. D., Terron-Kwiatkowski, A., Sandilands, A., Campbell, L. E., Zhao, Y., Liao, H., Evans, A. T., Goudie, D. R., Lewis-Jones, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1743 · Cited by 1,034 · cited 1×
“Recent genetic studies have shown that loss-of-function mutations in the gene encoding FILAGGRIN underlie ichthyosis vulgaris (6), a very common genetic disorder of keratinization.”
BackgroundMutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome
Chavanas, S., Bodemer, C., Rochat, A., Hamel-Teillac, D., Ali, M., Irvine, A. D., Bonafé, J.-L., Wilkinson, J., Taïeb, A., Barrandon, Y., et al. (2000) · Nature Genetics · doi:10.1038/75977 · Cited by 856 · cited 1×
“We previously identified serine protease inhibitor Kazal-type 5 (SPINK5) as the defective gene in NS (26).”
BackgroundSelf-citationγ-Secretase-mediated proteolysis in cell-surface-receptor signalling
Fortini, M. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm910 · Cited by 824
Allakhverdi, Z., Comeau, M. R., Jessup, H. K., Yoon, B.-R. P., Brewer, A., Chartier, S., Paquette, N., Ziegler, S. F., Sarfati, M., & Delespesse, G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062211 · Cited by 786
Cited by
Items 401–500 of 508
Αnti-KLK5/KLK7 Antibody-based Strategies for the Treatment of Epidermal Diseases
Pampalakis, G. (2023) · Current Pharmaceutical Design · doi:10.2174/0113816128258924231011103813 · Cited by 2
Ониковна, А. К., Murashkin, N. N., Makarova, S. G., Petrichuk, S. V., & Купцова, Д. Г. (2023) · Вопросы современной педиатрии · doi:10.15690/vsp.v22i5.2645 · Cited by 2
Nouwen, A. E. M., Ragamin, A., Knol, M. J., Ott, H., Weibel, L., Has, C., Hovnanian, A., Paller, A. S., Bodemer, C., Dalm, V. A. S. H., et al. (2024) · Dermatology · doi:10.1159/000542215 · Cited by 2
Self-citationKaushal, P., & Awasthi, R. (2025) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2025.100404 · Cited by 3
Weng, Y., Wang, J., Yang, Z., Xi, M., Duan, J., Guo, C., Yin, Y., Segawa, R., Moriya, T., Yonezawa, T., et al. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.01.005 · Cited by 3
Yong-Rodríguez, A., Macías-Weinmann, A., Palma-Gómez, S., Arias‐Cruz, A., Pérez-Vanzzini, R., Gutiérrez-Mujica, J. J., & Díaz, S. N. G. (2015) · Revista Alergia México · doi:10.29262/ram.v62i2.70 · Cited by 4
Syndrome dermorespiratoire : un phénotype sévère
Thi, T. N. P., Scheinmann, P., Karila, C., Laurent, J., Paty, E., & Jacques de, B. L. I. C. (2011) · Revue française d'allergologie · doi:10.1016/j.reval.2011.01.005 · Cited by 2
Hatano, Y. (2015) · Dermatologica Sinica · doi:10.1016/j.dsi.2015.03.007 · Cited by 2
Atopic Dermatitis, The Skin‐Disease
Wallach, D. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14487 · Cited by 2
Numerical analysis of chloride corrosion of reinforced concrete
German, M., & Zaborski, A. (2011) · Repozytorium Politechniki Krakowskiej · Cited by 2
Skin Barrier-Related Pathogenesis of Atopic Dermatitis
Choi, E. H. (2021) · Springer eBooks · doi:10.1007/978-981-15-8159-5_7 · Cited by 2
Skin Immune System: Microanatomy
Ono, S., & Kabashima, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.07008-9 · Cited by 3
Di, W., & Harper, J. I. (2011) · Harper's Textbook of Pediatric Dermatology · doi:10.1002/9781444345384.ch124 · Cited by 2
Di, W., & Harper, J. I. (2019) · Harper's Textbook of Pediatric Dermatology · doi:10.1002/9781119142812.ch132 · Cited by 2
Keratinocytes coordinate inflammatory responses and regulate development of secondary lymphedemaPreprint
Park, H. J., Kataru, R. P., Shin, J., Nores, G. D. G., Encarnacion, E. M., Klang, M. G., Riedel, E., Coriddi, M. R., Dayan, J. H., & Mehrara, B. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.20.524936 · Cited by 4
“11 Syndrome, inflammatory skin lesions, and increased Th2 cell infiltration.(52) In contrast, KLK5 1”
Targeting PAR-2 in atopic dermatitis: Preclinical evaluation of the novel inhibitor E6795
Kitayama, N., Nakashima, C., Sawada, T., Tanaka, N., Hagiwara, M., Otsuka, A., & Kabashima, K. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152590 · Cited by 1
Kinin receptors in adipose tissue: drivers of inflammation and metabolic dysfunction in obesity
Cárdenas, A., Armijo, C., Salazar, M., Villarroel, P., Catalán, M., Rojas-Mancilla, E., & Ehrenfeld, P. (2025) · Inflammation Research · doi:10.1007/s00011-025-02147-9 · Cited by 1
“KLKs can directly promote inflammation by cleav - ing Protease-Activated Receptors (PARs) on cell surfaces, which then trigger the production of cytokines like IL-8 and TNF-α [ 13, 14].”
Zingkou, E., Bisyris, E., Pampalakis, G., & Sotiropoulou, G. (2026) · The Journal of Pathology · doi:10.1002/path.70018 · Cited by 1
“Based on in vitro experiments, KLK5 was hypothesized to activate PAR2 to drive the in fl ammatory reaction in the epidermis [13].”
InfluentialLi, Y., Li, H., Zhang, Q., Cui, S., Zhai, Q., Stanton, C., Ross, P. M., Zhao, J., Chen, W., & Yang, B. (2026) · Food & Function · doi:10.1039/d5fo05688h · Cited by 1
Critical role of keratinocytes and protease‐activated receptor 2 in secondary lymphedema development
Park, H. J., Pal, S., Chen, X., Shin, J., Nores, G. D. G., Baik, J. E., Stull-Lane, A. R., Book, A. J., Clement, C. C., Encarnacion, E. M., et al. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70682 · Cited by 1
“66 In contrast, KLK5 inhibition reverses the pathology of Netherton syndrome.”
LEKTI: Netherton Syndrome and Atopic Dermatitis
Oiso, N., & Kaw, A. (2013) · InTech eBooks · doi:10.5772/53574 · Cited by 1
“Lack of LEKTI causes stratum corneum detachment secondary to epidermal proteases hyperactivity.[11] This skin barrier defect favors allergen absorption and is generally regarded as the underlying cause for atopic dermatitis-like lesions in Netherton syndrome.”
BackgroundInfluentialThe Itch-Scratch Cycle: Quality of Life Assessment and Management of Atopic Eczema in Children
Wolz, S. B. M. M. (2014) · Pediatrics & Therapeutics · doi:10.4172/2161-0665.1000198 · Cited by 1
“In 2009, a French research group convincingly showed that the inflammation of AE can be the product of uncontrolled protease activity and that such inflammation can occur independently of environmental influences and independently of the adaptive immune system [12].”
BackgroundThe Significance of Atopic Dermatitis
Wallach, D. (2016) · Journal of Dermatological Research · doi:10.17554/j.issn.2413-8223.2016.01.5 · Cited by 1
Interface between Thrombosis, Inflammation, and Angiogenesis in Cancer Progression
Mousa, S. A., Muralidharan-Chari, V., & Davis, P. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802576-5.00004-8 · Cited by 1
Search for Compounds Regulating TSLP Production
Segawa, R. (2021) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.21-00129 · Cited by 1
Functional Defense Mechanisms of the Nasal Respiratory Epithelium
Kern, R. C., & Decker, J. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-12386-3_4 · Cited by 1
Nouwen, A. E. M., Zaeck, L. M., Schappin, R., Geers, D., Gommers, L., Bogers, S., Dik, W. A., Pasmans, S. G. M. A., GeurtsvanKessel, C. H., de Vries, R. D., et al. (2024) · Journal of Clinical Immunology · doi:10.1007/s10875-024-01828-0 · Cited by 1
“Secondary secretion of pro-allergic and pro-inflammatory cytokines, such as thymic stromal lymphopoietin, tumor necrosis factor-a, intercellular adhesion molecule 1, and interleukin-8, leads to inflammatory and allergic predisposition [ 5, 10, 11].”
BackgroundTrefzer, L. K., Davidovic, M., Li, D., Karakioulaki, M., Casetti, F., Schempp, C. M., Eyerich, K., & Has, C. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.20482 · Cited by 1
“In patients with Netherton and SAM syndrome, severe atopy 8,9 was the rationale for the switch to drugs against Type 2 inflammation.”
Eiumtrakul, W., Wittayakornrerk, S., Wongkittichote, P., Nujaroen, S., Pakhathirathien, P., & Wattanasirichaigoon, D. (2025) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.64018 · Cited by 1
“This, in turn, increases the production of NFkB-dependent cytokine via protease activated receptor 2 (PAR2) activation and causes atopic dermatitis-like lesions (Nauroy and Nyström 2020; Briot et al. 2009; Furio et al. 2015).”
Eissa, A., & Diamandis, E. P. (2011) · Springer eBooks · doi:10.1007/978-3-0348-0157-7_3 · Cited by 1
“In LEKTI-deficient epidermis, hyperactive KLK5 activates PAR2 by proteolytic cleavage, and induces NFkB-mediated ICAM, IL-8, TNF-a, and TSLP cytokine overexpression [ 16 ].”
InfluentialKallikrein-Related Peptidase 8 (KLK8): The Structure and Function in the Epidermis
Kishibe, M. (2014) · Cited by 1
Functional Defense Mechanisms of the Nasal Respiratory Epithelium
Kern, R. C., & Decker, J. R. (2013) · Springer eBooks · doi:10.1007/978-3-642-37250-6_3 · Cited by 1
He, Z., Zhan, X., Zheng, Q., Zhu, L., Wang, X., Deng, L., & Bin, L. (2017) · Journal of Dermatological Research · doi:10.17554/j.issn.2413-8223.2017.02.30 · Cited by 1
Werfel, T., Heratizadeh, A., Aberer, W., Augustin, M., Biedermann, T., Bauer, A., Fölster‐Holst, R., Kahle, J., Kinberger, M., Nemat, K., et al. (2024) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.15230_g · Cited by 2
Thymic Stromal Lymphopoietin (TSLP): TSLP in Allergy, Autoimmunity, and Cancer
Ziegler, S. F., Roan, F., Bell, B. D., Stoklasek, T. A., Kitajima, M., & Han, H. (2013) · Springer eBooks · doi:10.1007/978-4-431-54442-5_12 · Cited by 1
Natural history of Atopic dermatitis-Outside-Inside-Outside Story-
Yamada, H. (2010) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.33.118 · Cited by 1
Oboki, K., & Saito, H. (2011) · Wiley eBooks · doi:10.1002/9781444346688.ch24 · Cited by 1
Yew, Y. W. (2020) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/151482 · Cited by 3
A fast non-parametric test of association for multiple traitsPreprint
Garrido-Martín, D., Calvo, M., Reverter, F., & Guigó, R. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.06.493041 · Cited by 1
2.Kallikrein-related peptidases―皮膚バリア機能における役割と炎症性皮膚疾患における意義―
岸部, 麻. (2014) · 日本皮膚科学会雑誌 · doi:10.14924/dermatol.124.315
Current and Novel Approaches for Genetic Skin Disorders
Lai‐Cheong, J. E., & Paller, A. S. (2013) · Springer eBooks · doi:10.1007/978-3-642-39532-1_11
Sagita, C., & Kabashim, K. (2012) · InTech eBooks · doi:10.5772/25609
Tacrolimus ointment for long-term treatment of atopic dermatitis
Mandelin, J. M. (2010) · Helda - University of Helsinki Institutional Repository
Kardon, A. P., & Ross, S. E. (2013) · doi:10.1002/9781118398890.ch9
“Furthermore, Netherton syndrome, a severe genetic skin disease characterized by unrelenting atopic dermatitis-like skin lesions, results from a loss-of-function mutation in the gene encoding the serine protease inhibitor Kallikrein 5 that leads to significantly elevated levels of epidermal serine proteases (Briot et a…”
BackgroundGenetic studies of skin barrier defects with focus on atopic dermatitis
Winge, M. C. G. (2012) · Figshare · Cited by 2
Yu, H. S. (2010) · Journal of Life Science · doi:10.5352/jls.2010.20.4.503
The role of the ion channel, TRPA1, in itch transduction in the mammalian peripheral nervous system.
Wilson, S. R. (2015) · eScholarship (California Digital Library)
Immunobiology of Chronic Rhinosinusitis
Incaudo, G. A., & Chang, C. C.-C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0265-1_3
Dosis antiinflamatorias de doxiciclina en el tratamiento de la rosácea
Hasbún, P., Vial, V., Soto, D., Silva, C., & Vélez, J. (2015) · Piel · doi:10.1016/j.piel.2015.09.019
Corstruction and Impairment of Skin Barrier Functions Originated from Keratinocytes
Hatano, Y. (2013) · The Nishinihon Journal of Dermatology · doi:10.2336/nishinihonhifu.75.399
Pharmacological Targeting of Human Tissue Kallikrein-Related Peptidases
Pampalakis, G., & Sotiropoulou, G. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849733151-00199
Epicutaneous sensitization and asthma
Asano, K. (2016) · Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology · doi:10.3388/jspaci.30.184
Atopische Dermatitis: Allergie oder Barrierestörung?
Bieber, T. R. M. (2013) · Fortschritte der praktischen Dermatologie und Venerologie · doi:10.1007/978-3-642-24767-5_1
Ruzicka, T., Wolff, H. J., Thomas, P. T., & Prinz, J. C. (2011) · Fortschritte der praktischen Dermatologie und Venerologie · doi:10.1007/978-3-642-10358-2_5
Characterization of Kallikrein-related Peptidase-8 in Normal Human Epidermis and Psoriasis
Eissa, A. (2014) · TSpace (University of Toronto)
Acidification of stratum corneum prevents atopic march in murine models
이해진 (2016) · YUHSpace (Yonsei University Medical Library)
INVESTIGATION OF THE PUTATIVE BIOLOGICAL SUBSTRATES FOR HUMAN KALLIKREIN-RELATED PEPTIDASE 7
Yu, Y. (2017) · TSpace (University of Toronto)
Recent findings on house dust mite allergen components
Nambu, M. (2018) · Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology · doi:10.3388/jspaci.32.698
CLINICAL APPROACHES TO THE PREVENTION OF ATOPIC DERMATITIS CHILDREN: EUROPEAN GUIDELINES 2018
Знаменська, Т. К., & Vorobiova, O. V. (2019) · Neonatology surgery and perinatal medicine · doi:10.24061/2413-4260.ix.1.31.2019.13
Atopic dermatitis and kallikrein-related peptidases
Morizane, S. (2019) · Okayama Igakkai Zasshi (Journal of Okayama Medical Association) · doi:10.4044/joma.131.17
Mutrual Association between Permceability Barrier Dysfunction and Allergic Inflammation
Hatano, Y. (2019) · The Nishinihon Journal of Dermatology · doi:10.2336/nishinihonhifu.81.87
Atopic Dermatitis and Kallikrein-related Peptidases
Morizane, S. (2019) · The Nishinihon Journal of Dermatology · doi:10.2336/nishinihonhifu.81.367
SnapshotDx Quiz: September 2020
McEvoy, A. M., Dube, U., Musiek, A. C. M., & Anadkat, M. J. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.06.014
Provozieren konvergierende zelluläre und Signalübertragungs‐Störungen die atopische Dermatitis?
Elias, P. M., & Wakefield, J. S. (2020) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14232_g
Epidermal Kallikrein-Related Peptidases
Kishibe, M. (2021) · The Nishinihon Journal of Dermatology · doi:10.2336/nishinihonhifu.83.99
Na+/H+ Exchanger 1(NHE1)の機能低下は皮膚の保湿およびバリア機能に影響する
祐子, 村., Okuno, R., 浩, 田., 靖司, 長., 八代洋一, & 悟, 中. (2019) · 日本香粧品学会誌 · doi:10.11469/koshohin.43.1
Nauroy, P., Zingkou, E., Sotiropoulou, G., & Kiritsi, D. (2021) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14396_g
Castillo, L., & Manuel, J. (2012)
Alvarez-Buylla, E. R., Martínez‐García, J. C., Dávila-Velderrain, J., Domínguez‐Hüttinger, E., & Martínez-Sánchez, M. E. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-89354-9_3
Kobayashi, T., & Nagao, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-29785-9_22 · Cited by 1
Thymic Stromal Lymphopoietin (TSLP)
Du, J., & Zhou, B. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101973
Thymic Stromal Lymphopoietin (TSLP)
Du, J., & Zhou, B. (2017) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101973-1
Lerner, E. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-33142-3_2 · Cited by 1
Inherited Disorders of Cornification
Oji, V., Süßmuth, K., Metze, D., Martín, Á. H., & Traupe, H. (2024) · Wiley eBooks · doi:10.1002/9781119709268.rook063
Martins, D., Pinoteau, M.-A., & Léger, R. (2024) · Analytical Biochemistry · doi:10.1016/j.ab.2024.115524
Unravelling the Complexities and Recent Advances in the Management of Atopic Dermatitis
Pandey, V. P., Punniyamoorthy, S., Pradhan, S., Umar, M., Bano, U., Pokharel, Y. R., Karwasra, R., Umar, T., & Kumar, P. (2024) · Current Drug Therapy · doi:10.2174/0115748855299561240802111649
Immunological phenotype and skin modeling of Netherton syndrome
Süßmuth, K., Traupe, H., Wittkowski, H., Fischer, J., Oji, V., & Bodes, J. (2025) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.15928
“26 However, a blockade of PAR2 did not improve inflammation in a NTS mousemodelinapreviousreport,althoughitreducedTSLP levels.”
LEKTI-Grafted Sunflower Trypsin Inhibitor: A Potential Therapeutic for Skin Diseases
Mah, J., Jayarajan, V., Huang, X., Di, W., & Macmillan, D. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01912
“46,47 Activated PAR2 causes protein kinase C (PKC) and inositol 1,4,5-trisphosphate (IP3) activation, leading to calcium release from the endoplasmic reticulum, known as intracellular calcium mobilization.”
Immunologischer Phänotyp und Hautmodelle des Netherton‐Syndroms
Süßmuth, K., Traupe, H., Wittkowski, H., Fischer, J., Oji, V., & Bodes, J. (2025) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.15928_g
Ghafoor, A. A. A., Waked, J. A. A., Maazi, M., Maliyar, K., Abduelmula, A., Sibbald, C. J., Mainville, L., & Croitoru, D. O. (2025) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/12034754251404463
Additional file 1 of A fast non-parametric test of association for multiple traits
Garrido-Martín, D., Calvo, M., Reverter, F., & Guigó, R. (2023) · Figshare · doi:10.6084/m9.figshare.24303326
Additional file 2 of A fast non-parametric test of association for multiple traits
Garrido-Martín, D., Calvo, M., Reverter, F., & Guigó, R. (2024) · Figshare · doi:10.6084/m9.figshare.24303447
Skin Immune System: Microanatomy
Ono, S., & Kabashima, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00504-4
Segawa, R., Yagisawa, M., Miyata, C., & Hirasawa, N. (2026) · PLoS ONE · doi:10.1371/journal.pone.0341552
“TSLP is produced by epithelial cells in response to inflammatory cytokines [7], toll-like receptor ligands [8], and proteases [9].”
The Role of Macrophages in Atopic Dermatitis
Chen, X., Shi, J., Wu, H., & Li, H. (2026) · Dermatologic Therapy · doi:10.1155/dth/6142669
Neuroimmune interactions in itch
Deng, L., & Chiu, I. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34172-4.00007-0
Mena, A. M. (2017) · theses.fr (ABES) · doi:10.70675/43188209zc3cdz4a72z9316z64f11f796f0d
Etude du rôle de PAR-2 dans l'inflammation neurogène cutanée
Gouin, O. (2017) · theses.fr (ABES) · doi:10.70675/6cf8c975z43d3z455ez86cez92aa33c410ee
Sadacca, B. (2017) · theses.fr (ABES) · doi:10.70675/86d0b41azfb6bz44bdz9f35zf24452ba9c6a
Trichot, C. (2019) · theses.fr (ABES) · doi:10.70675/9c2b2117zac89z4b38z843bz377e2f099448 · Cited by 2
Reconstitution in vitro des réponses immunitaires initiales dans la dermatite atopique
Brulefert, A. (2020) · theses.fr (ABES) · doi:10.70675/4f0faf3cz1452z496dz8fe2z3a669eab038a
Molecular and cellular mechanisms driving allergic skin sensitization and the atopic march
Segaud, J. (2022) · theses.fr (ABES) · doi:10.70675/8d7e179azb19cz4d43z8d3bzc40aee9279af
Computational modeling approaches to multifactorial aspects of atopic dermatitis
Greugny, E. T. (2022) · theses.fr (ABES) · doi:10.70675/1a512e85z6b7bz4cccz8338z4431a1300e4f
IgE Production Beyond Classical T-Cell Help
Jo, B., & Lim, J. (2026) · Immune Network · doi:10.4110/in.2026.26.e22
“Similarly, in Netherton syndrome, loss of SPINK5 unleashes stratum-corneum kallikreins (KLKs), disrupting epidermal integrity and provoking chronic barrier damage (33).”
The Role of Skin Surface pH in Age Associated Pruritus: Mechanistic and Clinical Insights
Pielak, R. M., & Butler, D. C. (2026) · American Journal of Clinical Dermatology · doi:10.1007/s40257-026-01061-y
“1) [43, 53, 66].”
Kim, H. L., Kim, D. E., Zhang, K., Kim, S. M., Kim, S. H., Jung, Y. W., Bischof, N., Choi, J., Kim, T., & Park, C. O. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1878876
“This culminates in defective barrier function and promotes Th2-skewed inflammation via protease-activated receptor 2 (PAR2)-mediated thymic stromal lymphopoietin (TSLP) induction, mirroring the pathophysiology observed in AD (41, 42).”
Liu, D., DUCA, E. D., Delaleu, N., Lau, M., Pulsinelli, J., da Rosa, J. C., Bar, J., Estrada, Y. D., Gudjonsson, J. E., Julia, V., et al. (2026) · Allergy · doi:10.1111/all.70505
Metadata
- Authors
- Briot, A., Deraison, C., Lacroix, M., Bonnart, C., Robin, A., Besson, C., Dubus, P., & Hovnanian, A.
- Affiliations
- Université Toulouse III - Paul Sabatier (FR)
- Institut National de la Santé et de la Recherche Médicale, U563, Toulouse F-31300, France 1
- Université Bordeaux Segalen (FR)
- Corresponding author
- Hovnanian, Alain
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2009-05-04
- Volume
- 206
- Issue
- 5
- Pages
- 1135-1147
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2715042
- OpenAlex
- W2144344238
- Cited by
- 504
- References
- 71
- Citations by year
- 2026: 17 · 2025: 14 · 2024: 22 · 2023: 18 · 2022: 32 · 2021: 24 · 2020: 30 · 2019: 37 · 2018: 22 · 2017: 31 · 2016: 40 · 2015: 30 · 2014: 42 · 2013: 42 · 2012: 33
- FWCI
- 42.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-05-MRAR-0009)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
- Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
- Keywords
- Netherton syndrome, kallikrein 5, SPINK5, LEKTI, atopic dermatitis, protease-activated receptor 2, thymic stromal lymphopoietin, keratinocytes, NF-κB signaling, Th2 cytokines, skin barrier dysfunction, eosinophilic dermatitis, mast cell infiltration, protease signaling, atopy
- MeSH terms
- Serine Peptidase Inhibitor Kazal-Type 5, Animals, Dermatitis, Atopic, Epidermis, Inflammation, Kallikreins, Mice, Nude, Skin, Serpins, Skin Transplantation, Mice, Knockout, Dermis, Mice, Keratin-14
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.